1. Home
  2. TIL
  3. TIL News

Latest Instil Bio Inc. (TIL) News on September 17, 2025

Instil Bio Announces ImmuneOnco’s Presentation of ‘2510 Monotherapy Data in Patients with 2L+ Squamous NSCLC at the 2025 World Conference on Lung Cancer (WCLC)

GlobeNewswire

7 days ago

Instil Bio Announces ImmuneOnco’s Presentation of ‘2510 Monotherapy Data in Patients with 2L+ Squamous NSCLC at the 2025 World Conference on Lung Cancer (WCLC)

MT Newswires

4 months ago

Top Premarket Gainers

MT Newswires

a year ago

Top Premarket Gainers

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Acumen Pharmaceuticals Inc Earnings Call

Share on Social Networks: